Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Ovarian Neoplasms 1Osteoporosis 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia 1

Interventions

Flow Cytometry 3Psychiatric Rehabilitation 2Methylprednisolone 2Immunologic Techniques 2Azacitidine 2Alemtuzumab 2thymoglobulin 1sargramostim 1ruxolitinib 1rucaparib 1dexamethasone acetate 1dexamethasone 21-phosphate 1cc-486 1aldesleukin 1abiraterone 1Zoledronic Acid 1Therapeutics 1Tacrolimus 1Stem Cell Transplantation 1Standard of Care 1Rituximab 1Prednisone 1Practice Guidelines as Topic 1Palliative Care 1Paclitaxel 1Moxifloxacin 1Microarray Analysis 1Interleukin-12 Subunit p35 1Interferon-alpha 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × Calcium Citrate × Gynecologic × Clear all
NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡